Rimegepant is an orally administered, small-molecule, calcitonin gene-related peptide receptor antagonist that may be effective in acute migraine treatment.
Domain | rimegepantantagonist.com |
---|---|
Homepage URL | https://rimegepantantagonist.com/design-of-radial-artery-simulator-program-according-to-waveform-drive/ |
Keywords | rimegepant antagonist threonin kinase modulator genetic regulation |
Sprache | englisch |